News Snapshot:
Chinese official pledged to optimize processes and spare no efforts in putting COVID-19 vaccines on market as early as possible while adhering to laws and regulations and ensuring safety and effectiveness. The safety and effectiveness of the COVID-19 vaccines must comply with relative standards, pass the process validation of mass production and set up controllable quality standards, said Yang Sheng, an official with the National Medical Products Administration, at a press conference in Beijing on Friday. Up till now, there have been 11 Chinese COVID-19 vaccines entering clinical trials, with four in phase-3 clinical trials. The duration of phase-3 clinical...
